Scar formation following injury is a common problem that causes aesthetic distress and functional problems for those afflicted. Recently, pharmacological intervention of scar-promoting cellular activities has gained traction based on the emerging scientific evidence proving efficacy and safety of new therapeutics in preclinical studies. Ideal new drug therapies would be noninvasive, inexpensive, safe-to-use, and effective in prevention of scar formation. Recently, cytokine-based therapies and modulators of mechanotransduction are being evaluated for their anti-fibrotic properties in the reduction and prevention of scarring
Related Posts
Hope in Every Sample: TESE and the Journey to Fatherhood
Testicular Sperm Extraction (TESE) is a surgical procedure employed in male infertility cases where sperm retrieval from the testicles is necessary. During TESE, a small tissue sample is extracted from the testicles, and the contained sperm is subsequently used for assisted reproductive techniques such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). This […]
Advancing CRISPR/Cas Biosensors for Disease Detection & Treatment
CRISPR/Cas technology’s endonuclease activity has spurred genome editing, bioanalytical sensors, and disease diagnostics, notably for SARS-CoV-2 variants. Multiplexing capabilities enable sensitive detection of nucleic acids, proteins, and more. Despite successes, challenges persist, like limited multiplexing assays and off-target effects. Microfluidic integration shows promise but complexity delays immediate application. Spectral limitations in fluorescence-based assays hinder biomolecule […]
Okra is low in calories but packed full of nutrients. The vitamin C in okra helps support healthy immune function
Share via: Facebook X (Twitter) LinkedIn More